Geron Corp.


Market Cap$2.04B

Compare Geron

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Geron Corp.Geron Corp.-11.10%-74%-0.3
marketMarket Avg59.71.27%30%-0.9
HealthcareHealthcare Avg64.51.29%15%7.10.8

Target Price by Analysts

34% upsideGeron Target Price DetailsTarget Price

Current Fair Value

100.9% downside

Overvalued by 100.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.04 Billion
Enterprise Value$1.79 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.32
Outstanding Shares546,873,894
Avg 30 Day Volume10,852,408


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-11.08
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue7544.66
Enterprise Value to EBIT-9.22
Enterprise Value to Net Income-10
Total Debt to Enterprise0.05
Debt to Equity0.33

Revenue Sources

No data

ESG Score

No data

About Geron Corp.

CEO: John Scarlett